Join our Mailing list!
Get all latest news, exclusive deals and updates.
Estd. 2016
Health Tech Product
CorFlow Therapeutics is a Switzerland-based developer of a novel diagnostic and drug delivery medical device designed to diagnose and address microvascular disease, specifically microvascular obstruction (MVO), in patients suffering from heart attack. Known as the CoFITM System, the device could improve the treatment of heart attack patients with MVO in the future, improving their therapeutic outcomes.
Team Members
| First Name | Last Name | Designation | Paul | Mead | Chief Executive Officer and Board Member | Click Here |
|---|---|---|---|
| First Name | Last Name | Designation | Oliver | Bludau | Chief Operating Officer, Head of Operations and Research and Development Director | Click Here |
Job
No data was found